相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-term safety and tolerability of oral tofacitinib in patients with Crohn's disease: results from a phase 2, open-label, 48-week extension study
Julian Panes et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
BIOLOGICAL EVIDENCE OF TOFACITINIB EFFICACY IN CROHN'S DISEASE
Evangelos Theodorou et al.
GASTROENTEROLOGY (2018)
Sex-Based Differences in Incidence of Inflammatory Bowel Diseases-Pooled Analysis of Population-Based Studies From Western Countries
Shailja C. Shah et al.
GASTROENTEROLOGY (2018)
POST-HOC ANALYSIS OF TOFACITINIB CROHN'S DISEASE PHASE 2 INDUCTION EFFICACY IN SUBGROUPS WITH BASELINE ENDOSCOPIC OR BIOMARKER EVIDENCE OF INFLAMMATION
Bruce E. Sands et al.
GASTROENTEROLOGY (2018)
Gender differences in biologic treatment outcomes-a study of 1750 patients with psoriatic arthritis using Danish Health Care Registers
Pil Hojgaard et al.
RHEUMATOLOGY (2018)
Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials
Julian Panes et al.
GUT (2017)
A Phase 2 Study of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients With Crohn's Disease
William J. Sandborn et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
分享论文
